Paediatric brain tumours are most commonly found in the posterior fossa, particularly the cerebellum, where medulloblastoma, ependymoma and pilocytic astrocytoma are most prevalent. Cerebellar tumours are currently treated using non-specific therapies. They have few somatically mutated driver genes [1][2][3][4][5][6][7] 
Paediatric brain tumours are most commonly found in the posterior fossa, particularly the cerebellum, where medulloblastoma, ependymoma and pilocytic astrocytoma are most prevalent. Cerebellar tumours are currently treated using non-specific therapies. They have few somatically mutated driver genes [1] [2] [3] [4] [5] [6] [7] , which has impeded the understanding of their biology and resulted in the development of targeted therapies lagging behind other major cancer types. Nevertheless, childhood cerebellar tumour types are known to have distinct molecular subtypes with different clinical behaviours. Medulloblastoma is now known to comprise four molecularly distinct diseases (subgroups), with further clinical and molecular heterogeneity within each subgroup 1, [8] [9] [10] [11] . Sonic Hedgehog medulloblastoma (SHH MB), group 3 medulloblastoma (group 3 MB) and group 4 medulloblastoma (group 4 MB) are thought to originate in the cerebellum [12] [13] [14] [15] [16] [17] , whereas WNT MB arises from the lower rhombic lip of the developing brain stem 18 . Although SHH MB is thought to arise from the granule cell precursors (GCPs), careful examination of fully developed SHH MB revealed populations of cells displaying varying levels of differentiation and growth capacity, mirroring the temporal evolution of the developing GCP hierarchy 19 . The extent to which the other molecular subgroups of medulloblastoma recapitulate a similar developmental hierarchy is currently unclear. Ependymomas are found throughout the central nervous system, but in the cerebellum are thought to be largely limited to two variants, PFA and PFB [20] [21] [22] , and have been suggested to arise from regional radial glial-like cells 2, 23, 24 . Molecular subgroups of medulloblastoma and ependymoma have been delineated by transcriptomics as well as patterns of DNA CpG methylation, both of which have been suggested to reflect the cell of origin 25, 26 . The cerebellum is made up of a large variety of cell types, with many undergoing temporally regulated differentiation through defined developmental hierarchies [27] [28] [29] . GABAergic (γ-aminobutyric acidcontaining) neurons, including Purkinje cells and a variety of interneurons, arise from the ventricular zone, whereas glutamatergic neurons, including those of the cerebellar nuclei, the inner granule cell layer and the unipolar brush cells (UBCs), arise from the upper rhombic lip (URL). Cerebellar glial cells, including radial glia, astrocytes and Bergmann glia also arise from stem cells in the ventricular zone that produce a proliferating progenitor still present in the cerebellar cortex after birth [30] [31] [32] . In the past, transcriptional studies of bulk cerebellar tissue were performed on a complex mixture of GABAergic neurons, Article reSeArcH glutamatergic neurons, glia and non-neuronal cells. The use of mixed transcriptomes from normal bulk cerebellum precludes a meaningful comparison to the transcriptome or epigenome of cerebellar tumours. Massive changes during early development and the relative inaccessibility of the cerebellum inside the skull further complicate the study of the normal developing cerebellum, particularly from human samples. However, the recent development of large-scale single-cell RNA sequencing (scRNA-seq) permits the development of a 'cellular scaffold' 33,34 for cerebellar development in which the transcriptomes of distinct hierarchies can be determined at various points in time, and subsequently compared to the transcriptomes of childhood cerebellar tumours. Identification of temporally and lineage-restricted cell populations in the developing cerebellum that most closely mirror the transcriptome of cerebellar neoplasms could allow tumour cells of origin to be identified, as transcriptional similarity can be construed as good evidence for the lineage of cellular origin. Although it remains possible that a more differentiated cell could 'de-differentiate, ' or that a cell from another lineage hierarchy could 'trans-differentiate' during the process of transformation 32 , there is little evidence for de-differentiation or trans-differentiation in human brain tumours. Furthermore, because of the low mutational burden in cerebellar tumours, it would seem likely that the tumour remains similar to its cell of origin. The benefits of matching cerebellar tumours to their transcriptional best match from cerebellar development include the discovery of developmental checkpoints that are defective in cerebellar tumours, the development of clinically relevant mouse models, and direct comparison of tumour and normal cell transcriptomes to discover tumour-related changes in transcriptional programs. Insights into the process of transformation from a normal cerebellar cell to a cerebellar cancer cell could lead to the development of novel targeted therapies.
Cellular diversity in the developing mouse cerebellum
We isolated the mesial cerebellum (embryonic day (E)14-postnatal day (P)14) or hindbrain (E10-E12) from wild-type mice and performed scRNA-seq on more than 60,000 cells from five embryonic time points and four early postnatal time points (Fig. 1, Extended Data  Figs. 1a-c, 2 ). Unsupervised clustering of individual cell transcriptomes yielded more than 30 distinct clusters, many of which were heavily populated by cells from specific time points in development (Fig. 1) . Expression of known marker genes allowed the identification of clusters of progenitors belonging to glutamatergic (Atoh1), GABAergic (Ptf1a, Data  Figs. 1d, 4) . Stem cell-like clusters marked by Nestin expression were primarily seen early, whereas glutamatergic and GABAergic neuronal populations appeared in mid-development, and glial cells developed later overall. By contrast, non-central-nervous-system cells were found across all time points. Several distinct clusters of cells only appeared during restricted developmental time points, with many not found in the postnatal period (Extended Data Fig. 4) . We conclude that it is possible to use scRNA-seq to identify biologically distinct cerebellar cellular populations.
On the basis of known developmental relationships, and transcriptional similarity, we constructed pseudo-time trajectories for the various cerebellar lineages (Fig. 2, Extended Data Fig. 3 ). Nestin + early neural stem cells give rise to the two major lineages of the cerebellum: GABAergic cells from the ventricular zone and glutamatergic cells from the URL (Extended Data Fig. 3a) . Stem cells in the ventricular zone give rise to both GABAergic neurons (Purkinje cells and GABAergic interneurons) as well as the cerebellar glia (Fig. 2a, Extended Data  Fig. 3b, c) . The URL gives rise to excitatory neurons of the cerebellar nuclei, GCPs and UBCs (Fig. 2b, c, Extended Data Fig. 3d ). Clustering of scRNA-seq profiles combined with the construction of pseudo-time trajectories that largely conform to known patterns of cerebellar development allows us to build a 'single-cell genomic transcriptional scaffold' of cerebellar development (Extended Data Fig. 4 ).
Cerebellar tumours mirror embryonic cell populations
Using a carefully curated list of mouse and/or human orthologues and an algorithm to deconvolute complex RNA mixtures against a series of single-cell-type transcriptional profiles, we compared the transcriptomes of bulk human ependymomas (PFA and PFB, 43 tumours), as well as cerebellar pilocytic astrocytomas (C-PAs, 10 tumours) to distinct developmental clusters. PFA, PFB and C-PA are all transcriptionally most similar to the gliogenic progenitors-1 cell cluster (Extended Data Fig. 5) , with some similarity to the proliferating ventricular zone progenitors, and to a previously unknown cluster of 'roof-plate-like' stem cells which has transcriptional similarity to the developing roof plate (Lmx1a, Msx1, Bmp7) 35, 36 . The gliogenic progenitor cluster is observed initially at E12, peaks at E18 and has largely disappeared by P5 (Extended Data Fig. 4) . The roof-plate-like stem cells are seen much earlier, appearing only between E10 and E12 (Extended Data Fig. 4 ). This is consistent with PFA, PFB and C-PA being classified as gliomas, and previous studies that suggest that PFA arises from the regional radial glia 24 . Posterior fossa ependymomas and C-PAs are both histologically and clinically distinct from each other. Re-clustering of the gliogenic progenitors, early ventricular zone radial glia and roof-plate stem cells identifies eight distinct transcriptional clusters within this lineage (Extended Data Fig. 7 ). Both PFA and PFB remain transcriptionally best matched to the same developmental population (Extended Data  Fig. 7i ). However, C-PAs now transcriptionally match to a very distinct sub-cluster of the cerebellar gliogenic progenitor cell cluster, supporting a model in which posterior fossa ependymomas and C-PAs have distinct cells of origin (Extended Data Fig. 7i) .
By deconvoluting bulk RNA-seq transcriptomes from human medulloblastomas (SHH, group 3 and group 4 MB, total 145 tumours) against transcriptionally defined cerebellar clusters (Fig. 3) , we demonstrated that SHH MB shared most similarities to GCP clusters, as supported by previous publications 12, 13 . Re-clustering of cells in the GCP lineage revealed additional heterogeneity, with the identification of seven distinct clusters (Extended Data Fig. 8 ). Comparison of bulk human SHH MB transcriptomes to these seven GCP cell lineage clusters revealed heterogeneity within SHH MB (Extended Data Fig. 8c ). SHH MBs that transcriptionally resemble later time points in cerebellar development (SHH-1, similar to the postnatal GCPs 2.1) have a worse prognosis than those that resemble the earlier-arising GCPs (SHH-2, similar to the postnatal GCPs 1.1, P = 0.00442; Extended Data Fig. 8g) . Furthermore, SHH-β subtype medulloblastomas are more similar to the earlier Article reSeArcH SHH-2 subset, demonstrating the similarity of this subtype to differentiation states in earlier GCP development (Extended Data Fig. 8j ).
The cell of origin for group 3 MB is not yet definitively known but has been suggested to be a Nestin + cerebellar stem cell 16 . Comparison of group 3 MB to developmental cerebellar cell clusters revealed a broad resemblance across group 3 MB to Nestin + cerebellar early stem cells (Fig. 3) . Of interest, subsets of bulk group 3 MB transcriptomes also resemble developmental cell clusters in the GCP and UBC lineages, Article reSeArcH as well as showing similarity to cerebellar GABAergic interneurons (Fig. 3 ). This multi-lineage differentiation is consistent with a model in which group 3 MBs contain Nestin + early neural stem-like cells that give rise to a variety of differentiated progeny; however, this possibility cannot be evaluated properly using bulk RNA-seq data.
Mouse models of group 4 MB are not available, and the cell of origin for group 4 MB is unknown. Unexpectedly, group 4 MB was transcriptionally best matched to cells of the UBC lineage (Fig. 3) . UBCs are glutamatergic interneurons that derive from the URL, which have not been studied as closely as other types of cerebellar neurons 35 . The cluster that best matched group 4 MB (cluster 8; Extended Data Fig. 1 ) is first observed at E14, peaks in prevalence at E18 and has largely disappeared by P0 (Extended Data Fig. 4 ). Re-clustering of cells in the UBC lineage followed by comparison to the transcriptomes of bulk human group 4 MB affirms that in all cases, the bulk group 4 MB transcriptome is most similar to the UBC progenitor cell cluster (Extended Data Fig. 9g ). These data are consistent with a model in which group 4 MB arises from a cell in the UBC lineage.
Temporal mirroring of specific embryonic cell clusters
Different childhood tumours transcriptionally mirror specific clusters in defined cerebellar lineages. Many of these lineages are only detected over a defined period of development, whereas others persist into adulthood (Extended Data Fig. 4) . We compared human tumour transcriptomes to their best-matched developmental cluster as a function of time. Comparison of bulk PFA and PFB transcriptomes to single mouse cells in the gliogenic progenitor cell lineage from E10 to P0 revealed a specific match to the E16 gliogenic progenitors (Fig. 4a, b) . Similarly, C-PAs had a very strong match at both E16 and E18 (Fig. 4c) .
The gliogenic progenitor cells form a discrete cluster from E14 to P0 (Fig. 4d) , bracketing the period of highest transcriptional resemblance. Comparison of the bulk transcriptomes of human group 4 MB to mouse cells in the UBC lineage revealed that some group 4 MBs are transcriptionally similar to E16, whereas others are more similar to E18 (Fig. 4e) . The UBC lineage is well defined and detected from E14 to P0 (Fig. 4f) . Comparison of group 4 MBs that more closely mirror E16 to those that mirror E18 demonstrated that group 4-β is largely restricted to 'E16 similar' tumours, whereas group 4-γ is completely restricted to 'E18 similar' tumours 8 (P = 0.00004, Extended Data Fig. 9r ). These data suggest that differences between group 4-β and group 4-γ could be secondary to their arising at different time points in the UBC lineage 8 . We did not attempt to temporally position group 3 MBs using bulk transcriptomics, as group 3 MB often transcriptionally match more than one cluster in the developing cerebellum. Although PFA, PFB, C-PA and group 4 MB are all transcriptionally best matched to cell clusters present during fetal development, SHH MBs are best matched to the GCP lineage in the early postnatal period 12 at P5 (Fig. 4g, h) . We conclude that, in addition to transcriptional mirroring of specific cell populations in the developing cerebellum, human cerebellar tumour transcriptomes are most similar to specific time points during development, predominantly during fetal life.
Single-cell heterogeneity in cerebellar tumours
Medulloblastomas exhibit well-characterized intertumoral heterogeneity, as well as geographic, spatial (metastases) and temporal (at recurrence) heterogeneity Eomes (E15.5) Article reSeArcH scRNA-seq of human cerebellar tumours including medulloblastoma (eight patients), PFA ependymoma (four patients) and C-PA (three patients). Analysis of clusters from scRNA-seq of human tumours revealed both tumour cell clusters and non-tumour cell clusters (that is, endothelium, monocytes/microglia, lymphocytes; Extended Data Table 4 ). In keeping with our aim to compare tumour cells to cell populations in the developing cerebellum, nontumour cell clusters were removed from consideration. SHH MB scRNA-seq clusters remain most similar to cells in the GCP lineage (Fig. 5a ). Some SHH scRNA-seq clusters are most similar to the UBC and GCP progenitor cell cluster. Comparison to the seven re-clustered clusters in the GCP lineage revealed that SHH MBs contain cells that are transcriptionally similar to various different stages of GCP development (Extended Data Fig. 8c ). These results are consistent with a model in which SHH MBs contain a variety of tumour cell types that represent different stages of GCP differentiation and that might exhibit distinct clinical behaviours and therapeutic responses 19 . Identification and transcriptional mapping of individual tumour cell clusters from group 3 MB revealed highly divergent lines of differentiation, with tumour clusters similar to multiple normal developmental clusters in the GCP, UBC, Purkinje cell and GABAergic interneuron lineages. This pattern is consistent with an origin from a very early, uncommitted cerebellar stem cell, followed by partial differentiation of transformed cells along diverse developmental lineages (Fig. 5b) .
scRNA-seq of human group 4 MBs revealed discrete clusters that transcriptionally mirror the differentiated UBCs, as well as the UBC progenitors (Fig. 5c, Extended Data Fig. 9 ). Unexpectedly, we also observed tumour cell clusters from each human group 4 MB that are transcriptionally most similar to the GCP lineage (Fig. 5c) .
Comparison of group 4 MB single-cell tumour cluster transcriptomes to both the GCP and UBC lineages revealed that 'GCP similar' clusters are transcriptionally more similar to the GCP lineage than the UBC lineage (Supplementary Table 8, sheet 5) . By contrast, 'UBC similar' clusters are more similar to the UBC lineage (Supplementary Table 8 , sheet 4). Individual group 4 MBs contain highly variable percentages of differentiated versus less-differentiated cells (Extended Data  Fig. 9f) . Comparison of the group 4 MB scRNA-seq data revealed that UBC-like cells in group 4 MB transcriptionally mirror several time points in UBC development (Extended Data Fig. 9h ). Two distinct types of UBCs have been described in the mammalian cerebellum 42 . Consistent with this, re-clustering of mouse cerebellar cells in the UBC lineage revealed two distinct types of UBCs (Extended Data Fig. 9c ). Group 4 MB is predominantly similar to only one of these subtypes (Calb2 + UBCs; Extended Data Fig. 9h ). Individual cells from the UBC and GCP progenitor cluster simultaneously express both GCP and UBC marker genes, which is not observed in cells committed to a GCP or a UBC fate (Extended Data Fig. 10 ) but is observed in group 4 MB cells. These data are consistent with a model in which group 4 MB arises from a bipotential progenitor cell population (probably in cluster 8) that is capable of giving rise to cells in both the GCP and the UBC lineages.
Single-cell RNA-seq of PFA ependymomas revealed single-cell heterogeneity, with each tumour containing clusters that best matched sub-clusters of the gliogenic progenitor cell population or roof-platelike stem cells (Fig. 6a, Extended Data Fig. 7 ). Of note, we did not observe clusters of more-differentiated cell types such as Bergmann glia or astrocytes within the PFA ependymomas, but only lessdifferentiated cell types. This lack of differentiated cell types within the tumour is unique to PFA among the childhood cerebellar tumours examined in this study. Some single-cell transcriptional clusters of human PFA tumours are more similar to single-cell clusters from the tumour of another patient than they are to other clusters from the same individual (Extended Data Fig. 7d ). C-PA scRNA-seq also revealed clusters with transcriptional similarity to the relatively undifferentiated roof-plate-like stem cell cluster and the gliogenic progenitors (Fig. 6b) . Unlike PFA ependymoma, some C-PA tumour cell clusters demonstrate similarity to more differentiated cell types, such as astrocytes, Bergmann glia and oligodendrocytes (Fig. 6b) . 
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Discussion
Cumulatively, across the medulloblastoma subgroups (SHH, group 3 and group 4 MB), as well as PFA ependymoma and C-PA, our scRNAseq data demonstrated high levels of single-cell heterogeneity, with evidence of multiple lineages of differentiation and tumour cells matching different time points in the differentiation hierarchy. Childhood cerebellar tumour transcriptomes demonstrate high levels of similarity to discrete cell populations within the developing cerebellum, supporting a model in which discrete cells of origin have a profound influence on the transcriptome and biology of the observed mature tumours. Although the use of cell cycle genes is essential in defining developmental stages of cell populations in the cerebellum (that is, progenitor cell versus differentiated cell), we excluded cell cycle genes when comparing human tumour cells to developmental clusters in mice to avoid spurious comparisons based largely on cell cycle phenotypes (Supplementary Table 3 ); however, cell cycle content and genomic alterations were quantified independently in the human single-cell datasets (Extended Data Fig. 10, Supplementary Table 7) . The relative biological significance of clusters that are well separated in the t-SNE plots, versus those that are spread out and partially overlapping, is uncertain, and a well-known issue in single-cell sequence analysis that will require future investigation.
Many of the normal mouse cerebellar cell populations that are transcriptionally most similar to human cerebellar tumours are only present for a restricted time period during fetal development or are found only in the very early postnatal period. It is certainly possible that each of the cerebellar tumour types discussed above arises in a particular cell type indicated by the cluster and developmental time point identified by transcriptional matching. However, extensive cell lineage tracing using in vivo models of these diseases will be necessary to exclude the possibility that tumours arise in other cell lineages and undergo trans-differentiation during transformation, or arise in cerebellar cells at later time points and then undergo de-differentiation.
Our data do not reveal substantial populations of differentiated cells within PFA ependymomas, differentiated glia within medulloblastomas, or differentiated neuronal cell types within C-PAs. Distinguishing infiltrating normal cells within paediatric cerebellar tumours is difficult as these tumour types contain very few somatic genetic events that would allow us to discern transformed from non-transformed cells. The normal, non-transformed cell populations that transcriptionally best match cerebellar tumours are only present in utero, or immediately postnatally; these populations are therefore not present in the brains of children at the time of presentation and probably could not contaminate their tumours. However, we cannot exclude the possibility that some of the single-cell tumour clusters in our study also contain small populations of infiltrating non-transformed differentiated cells.
The ability of these different progenitor cell populations restricted to specific time points to give rise to different types of cerebellar tumours should ideally be tested functionally in vivo, as previously demonstrated 14,18,23,24 . Although there would be great value in comparing human cerebellar tumours to single-cell transcriptomes from normal human cerebellar cells from various time points in development, these types of samples are not readily available. The presence of multiple lineages and stages of differentiation within bulk medulloblastoma samples illustrates the difficulty of using the bulk tumour population as a tool to decipher tumour biology or to develop tumour diagnostics. The absence of differentiated cell types in PFA ependymomas, but not other tumour types, suggests the presence of a differentiation block in PFA ependymomas. The work presented here is focused on the relationship of posterior fossa tumours to cell types in the developing cerebellum. The current scRNA-seq datasets from posterior fossa tumours should allow further analyses and insights into both tumour-cell-autonomous and infiltrating non-tumour-cell biology. A more complete understanding of the biology and transcriptomes of the specific cerebellar hierarchies identified above, and their developmental timing, may allow a better comprehension of cerebellar tumour biology and promote the subsequent development of new mouse models, improved tumour diagnostics and eventually the development of new rational therapeutics based on the differences between tumour cells and their normal cells of origin.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-1158-7. 
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Data reporting.
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Patient recruitment. Recruitment of participants was in compliance with the ethical regulations of the Hospital for Sick Children and McGill University Health Centre. Sample size of participants was determined based on consent availability and diagnosis. Available patient characteristic information is described in Supplementary Table 2. All collection and experiments involving samples from patients with tumours were approved by McGill University Health Centre (Montreal) and by The Arthur and Sonia Labatt Brain Tumour Research/Hospital for Sick Children (Toronto). Animal experiments. All mouse breeding and procedures were approved by The Centre for Phenogenomics (Toronto). Mated C57BL/6J female mice were dissected in order to collect embryos from the following gestational time points: E10, E12, E14, E16 and E18. C57BL/6J pups were dissected to collect tissue from the following postnatal time points: P0, P5, P7 and P14. Tissue handling and dissociation. Fresh tumour tissue was collected at the time of resection. The tumour tissue was mechanically and enzymatically dissociated using a collagenase-based dissociation method as previously reported 43 . Early embryonic hindbrain structures were dissected from the gestational time points E10 and E12. An incision was made between the midbrain and hindbrain boundary, as well as between the prepontine hindbrain and pontine hindbrain, in order to isolate the isthmus and rhombomeres −1 and −2 at these early time points in development. Late embryonic cerebellar primordia were collected at embryonic time points E14, E16 and E18. All embryonic mouse dissections were performed under a Leica stereoscope with a pair of Moria ultra-fine forceps (Fine Science Tools). The tissue was transferred into ice-cold Leibovitz's medium, followed by single-cell dissociation with the Papain Dissociation System (Worthington Biochemical Corporation). Postnatal cerebella were dissected from the following time points: P0, P5, P7 and P14. The central nervous system was fully dissected, then embedded in 2% low melting point agarose. One mid-sagittal slice of 300 µm was generated using the Leica vibratome 44 . Under the stereoscope the cerebellum was isolated from the slice, followed by immediate single-cell dissociation as described above. Reverse transcription, amplification and sequencing. The concentration of the single-cell suspension was assessed with a Trypan blue count. Approximately 10,000-14,000 cells per time point were loaded on the Chromium Controller and generated single-cell GEMs (gel beads in emulsion). GEM-reverse-transcription, DynaBeads clean-up, PCR amplification and SPRIselect beads clean-up were performed using Chromium Single Cell 3′ Gel Bead kit. Indexed single-cell libraries were generated using the Chromium Single Cell 3′ Library kit and the Chromium i7 Multiplex kit. Size, quality, concentration and purity of the cDNAs and the corresponding 10× library was evaluated by the Agilent 2100 Bioanalyzer system. The 10× libraries were sequenced in the Illumina 2500 sequencing platform. Alignment of raw reads. Through 10× CellRanger's pipeline 45 , the raw base call (BCL) files were demultiplexed into FASTQ files. The FASTQ files were aligned to the reference mouse genome GRCm38 (mm10) to generate raw gene-barcode count matrices. When clustering multiple samples, we aggregated the multiple runs together to normalize on sequencing depth and re-computed the gene-barcode matrices. Alignment quality control metrics are found in Supplementary Table 1, sheet 1. Quality control and normalization. Low-quality cells were identified and removed from the datasets. We considered low-quality cells as cells with <200-300 genes expressed, and cells with high mitochondrial gene content (4 s.d. above median). We predicted doublets to be cells with relatively high library sizes (4-5 s.d. above median) and removed them from the analysis. Low-abundance genes were also removed from the datasets (genes expressed in <3 cells). The human single-cell datasets were normalized using methods adapted from Scran pipeline 46 . Size factors were computed and were applied to normalize gene expression across the cells, to produce normalized log-expression values to each dataset individually. Mouse single-cell datasets were processed using CellRanger aggregation in order to account for sequencing depth variation, followed by quality control and normalization as described above. Clustering analysis and visualization. Clustering analysis was performed with both the presence (Fig. 1) and absence (Extended Data Fig. 1 ) of cell cycle-related genes obtained from Ensembl's BioMart 47 . When implemented, removal of cell cycle genes was done before detection of highly variable genes (HGVs). HGVs were detected using Seurat's pipeline 48, 49 , calculating average expression and dispersion for each gene, diving genes into bins and computing a z-score for dispersion within each bin. We used a z-score of 0.5 as the cut-off of dispersion, and a bottom cutoff of 0.0125 and a high cut-off of 3.0 for average expression. Linear dimensionality reduction was performed using principal component analysis (PCA), and statistically significant principal components were selected using the elbow and jackstraw methods from Seurat. The clusters of cells were identified by a shared nearest neighbour (SNN)-modularity-optimization based clustering algorithm from Seurat. We then visualized these clusters using t-distributed stochastic neighbour embedding (t-SNE). Pseudo-time trajectory analysis. The barcodes of selected clusters were normalized using Monocle dPFeature to remove genes with low expression and perform PCA analysis on the remaining genes, for significant PC selection 50 . Cells were then grouped using 'density peak' clustering algorithm. Differential gene expression analysis was performed using a generalized linear model, and the top 1,000 genes per cluster were selected. Reversed graph embedding was then used to reduce the high-dimensionality data into lower dimensional space and build the trajectory 51 . The structure of the trajectory was plotted into two-dimensional space using the DRTree dimensionality reduction algorithm and order the cells in pseudo-time.
Creation of cell-type-specific signatures. For each cluster identified, the average expression of each gene was calculated. Differential gene expression was performed using Seurat's likelihood ratio test method and we filtered out genes expressed in less than 25% of the cells. The top differentially expressed genes were used as markers to build a signature gene expression matrix. Genes involved in cell proliferation and ribosome biogenesis were obtained from Ensembl BioMart 47 and omitted from the matrix. Human orthologues of mouse genes were identified and used to create the final matrix. Complete gene signatures and inputs can be found in Supplementary Tables 5 and 6 . Deconvolution analysis. CIBERSORT was used to perform the deconvolution analysis of the bulk and scRNA-seq tumour data against the mouse clusters 52 . The full transcriptomes of the tumour data were used as the input mixture, and the signature gene input was the mouse cluster expression matrix after removal of all genes that could introduce bias in the deconvolution process, including 1,400 cell cycle genes, 300 genes associated with ribosome biogenesis, and around 100 mitochondrial and apoptosis-related genes. Quantile normalization was disabled and 100-500 permutations were run. To test CIBERSORT on our datasets, we created synthetic bulk mixtures from the mouse clusters, and selected known amounts of reads from various clusters. CIBERSORT roughly yielded the expected relative abundances. In order to generate reliable input expression profiles, tumour clusters with a very low number of cells were discarded from the analysis. To validate our mouse cluster signatures, we obtained human and mouse data of brain cell types from published datasets 33, 34 (Supplementary Table 1 , sheet 2), and deconvoluted them against our mouse signatures to ensure that our expected abundances had similar values to our cell of origin matches. Bulk RNA-seq human tumour samples. A total of 60 SHH, 40 group 3 and 45 group 4 human medulloblastoma bulk RNA-seq samples were obtained from MAGIC, Medulloblastoma Advanced Genomics International Consortium. The raw data were aligned to the reference human genome GRChg38 using STAR to generate raw counts 53 . FPKMs were then obtained from DESeq2 54 . We performed bulk RNA sequencing on 22 PFA, 4 PFB and 10 C-PA patient samples, and obtained FPKMs using the same strategy. Microarray expression data were obtained from 17 PFB samples. Relative gene expression panels. Relative expression of genes within selected clusters was measured by calculating the average of the gene count from the lognormalized matrix in each cluster. The averages of specific genes were then scaled between the values of −1.0-1.0 among the selected clusters in order to reflect higher versus lower expression levels. Cell cycle analysis of human scRNA-seq tumour samples. Cell cycle phasespecific annotations were acquired from a previous publication 55 and used to quantify the percentage of phase-specific cell cycle genes in each individual cell. The percentages were then normalized from a scale 0-1, after which the ratio between G1/S and G2/M was calculated. Cells with low ratio values for the G2/M and G1/S ratios were labelled as in G0 phase, whereas cells with increasing values for G1/S but low ratio values were labelled as cells progressing into G1 phase. Cell with high ratio values for G2/M were labelled as cells progressing into S, G2 and M phase, respectively. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
The datasets generated and analysed during the current study are available in the Gene Expression Omnibus (GEO) and European Genome-phenome Archive (EGA; https://www.ebi.ac.uk/ega/studies/) repositories: BAMs and filtered gene matrices of mouse developmental time points scRNA-seq (GSE118068), FASTQs of PFB bulk RNA-seq and microarray expression (EGAS00001002696, GSE64415), BAMs of human tumour scRNA-seq and either BAMs or FASTQs of bulk PFA/C-PA RNA-seq (EGAS00001003170) and FASTQs of MB bulk RNA-seq (EGAD00001004435).
Code availability
The following packages were used for the data analysis: Cell Ranger v1.2.1, R v3.4.4, Seurat v1.4.0, v2.3.0 and v2.3.4, Monocle v2.6.3 and CIBERSORT (absolute mode beta). Fig. 6 | Clustering analysis and t-SNE visualization of human scRNA-seq data. a-e, t-SNE visualization of scRNA-seq data used as input for the CIBERSORT deconvolution analysis of SHH MB (n = 2), group 3 MB (n = 2), group 4 MB (n = 4), PFA (n = 4) and C-PA (n = 3) patient samples. Cluster annotations were established by expression of known marker genes unique to tumour and cell type and are defined as follows: SHH-1, tumour clusters: 1, 2, 3, 4, 5; monocyte/microglia: 6. SHH-2, tumour clusters: 1, 2, 3, 4, 7; monocyte/microglia: 5, 6; T cells: 8. G3-1, tumour clusters: 1, 2, 3, 5, 6; monocyte/microglia: 4. G3-2, tumour clusters: 1 ,2, 3, 5, 6 ,7; monocyte/microglia: 4. G4-1, tumour clusters: 1, 2, 3, 4, 5, 6; microglia/monocytes: 8; T cells: 7. G4-2, tumour clusters:1, 2, 3, 4, 5, 7; microglia/monocytes: 6. G4-3, tumour clusters: 1, 2, 3, 4, 5, 6, 7, 8, 9; monocytes/microglia: 10. G4-4, tumour clusters: 1, 2. PFA-1, tumour clusters: 4, 6; monocytes/microglia: 1, 3, 5; T cells: 2; B cells: 7. PFA-2, tumour clusters: 1, 2; monocytes/microglia: 3. PFA-3, tumour clusters: 1, 4, 6, 7; microglia/monocytes: 2, 3, 5. PFA-4, tumour clusters: 1, 3, 6, 7; monocytes/microglia: 2, 4, 5; T cells: 9; pericytes: 8; endothelial cells: 10. C-PA-1, tumour cluster: 3; monocytes/microglia: 1, 2, 4, 5, 6, 7, 9, 10, 11; T cells: 8. C-PA-2, tumour clusters: 4, 5, 7; monocytes/microglia: 1, 2, 3, 6, 8, 10, 11, 12; T cells: 9. C-PA-3, tumour clusters: 2, 4, 5, 7; monocytes/ microglia: 1, 3, 8; T cells: 6. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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